Qiagen

qiagen.comHealth and pharma

DAX 40

Level: 1; Basic web presence
Agent readiness score: 24
AEO score: 35
AI mention rate: 3%

Qiagen ranks 2nd of 12 for AEO score in the health and pharma industry, with AI engines naming the brand in 3.3% of answers. The agent readiness score is at level 1 (web basics) with 24 points, matching the industry median. Link header, markdown negotiation, llms.txt, content signals and API catalogue are not yet in place.

The next three steps

1Content Signals
Add a Content-Signal line for search, ai-input and ai-train to robots.txt.
A step toward level 2
2Markdown negotiation
Return a markdown version when asked with Accept: text/markdown, for example at the CDN.
3llms.txt
Publish an llms.txt with a short summary and the key links.

Compared with Health and pharma

Agent readiness24
Industry median 24 · rank 4 of 11
AEO score35
Industry median 27 · rank 2 of 12
Mentions in AI answers3
Industry median 3 · rank 5 of 12
Visibility53
Industry median 30 · rank 1 of 12
Citations1
Industry median 1 · rank 6 of 12
Sentiment50
Industry median 62 · rank 7 of 12

Agent readiness level

0Not yet agent-ready
1Basic web presence
2Bot-aware
3Agent-readable
4Agent-integrated
5Agent-native

To reach level 2:

Content Signals

Areas

Discoverability77
Content accessibility0
Bot access control32
APIs, auth and MCP0

Every check

Discoverability

robots.txtPassed
A valid robots.txt with crawl rules at the site root.
Top sites: 98%
SitemapPassed
An XML sitemap listing the pages, ideally referenced from robots.txt.
Top sites: 88%
Link headersNot met
Send Link headers such as rel="api-catalog" or rel="describedby" on the homepage.
Top sites: 0%
DNS for AI DiscoveryNot present
Advertise agent endpoints with SVCB records under _agents.
Top sites: 5%

Content accessibility

Markdown negotiationNot met
Return a markdown version when asked with Accept: text/markdown, for example at the CDN.
Top sites: 2%
llms.txtNot met
Publish an llms.txt with a short summary and the key links.
Top sites: 15%

Bot access control

AI bot rulesPartly met
Add explicit robots.txt groups for the main AI crawlers.
Top sites: 99%
Content SignalsNot met
Add a Content-Signal line for search, ai-input and ai-train to robots.txt.
Top sites: 2%
Web Bot AuthNot present
Only relevant if you run your own agents or crawlers: publish a signing key directory.
Top sites: 0%

APIs, auth and MCP

API CatalogNot met
List public APIs in a linkset at /.well-known/api-catalog.
Top sites: 0%
OAuth discoveryNot met
Publish OpenID Connect or OAuth server metadata under /.well-known.
Top sites: 1%
OAuth Protected ResourceNot met
Serve protected resource metadata at /.well-known/oauth-protected-resource.
Top sites: 1%
auth.mdNot met
Publish an auth.md describing how agents sign in.
Top sites: 0%
MCP Server CardNot met
Offer an MCP server and publish its server card under /.well-known.
Top sites: 0%
A2A Agent CardNot met
Publish an agent card at /.well-known/agent-card.json.
Top sites: 0%
Agent SkillsNot met
Publish a skills index with the main tasks agents can do.
Top sites: 0%
WebMCPNot met
Register key actions such as search or cart as WebMCP tools.
Top sites: 1%
ARD manifestNot met
Publish an ai-catalog.json listing every agent interface.
Top sites: 0%

AI crawler rules (robots.txt)

Training

GPTBotallowed
ClaudeBotallowed
Anthropic-AIallowed
Google-Extendedallowed
GoogleOtherallowed
Applebot-Extendedallowed
Meta-ExternalAgentallowed
FacebookBotallowed
Bytespiderallowed
CCBotallowed
AI2Botallowed
Cohere-AIallowed
Claude-Weballowed
Omgilibotallowed
Diffbotallowed

OAI-SearchBotallowed
Claude-SearchBotallowed
PerplexityBotallowed
Applebotallowed
Amazonbotallowed
YouBotallowed
Timpibotallowed

Assistant

ChatGPT-Userallowed
Claude-Userallowed
Perplexity-Userallowed
DuckAssistBotallowed
MistralAI-Userallowed

Agentic commerce

x402Not present
MPPNot present
UCPNot present
ACPNot present
AP2Not present

Protocols that let AI agents shop and pay by themselves. They don't count toward the level.

Agent readiness score 24 · coverage 100% · checked on 19/09/2026 · www.qiagen.com

Mentions per AI engine

AIOpenAI0/15 · 0%
CClaude1/15 · 7%
Sentiment: 0% positive, 100% neutral, 0% critical
PPerplexity1/15 · 7%
Sentiment: 0% positive, 100% neutral, 0% critical
GGemini0/15 · 0%

Spotlight: Gemini

0%0 of 15 answers name Qiagen

„Lohnt sich die Investition in Next-Generation-Sequencing für kleinere Labore?“

Die Anschaffung von Next-Generation-Sequencing (NGS) für kleinere Labore erfordert eine sorgfältige Abwägung zwischen hohen Anfangsinvestitionen und dem langfristigen Nutzen. Vorteile von NGS für kleinere Labore Erweitertes Leistungsspektrum: Das Labor kann komplexe genetische Analysen (z. B. in der Onkologie oder der Infektionsdiagnostik) direkt vor Ort anbieten. Kürzere Durchlaufzeiten: Interne Testungen …

AI answer as returned, unverified and shortened.

Gemini names instead

Next-Generation Sequencing (NGS)
Next-Generation-Sequencing
Polymerase-Kettenreaktion (PCR)
Illumina
Oxford Nanopore
SARS-CoV-2
Influenza
MRSA

Sources: synthego.com, neumodx.com, myadlm.org, biocompare.com, gesundheitsindustrie-bw.de, biotype.de

Share of voice

QIAGEN33.3%
Siemens Healthineers0%
Abbott Diagnostics Germany0%
Roche Diagnostics Deutschland0%
Bio-Rad Laboratories (Germany)0%
Thermo Fisher Scientific (Germany)0%

Most cited sources

1.trillium.de18
2.pmc.ncbi.nlm.nih.gov11
3.medicalexpo.de8
4.laborpraxis.vogel.de7
5.laborjournal.de7
6.chemie.de6
7.management-krankenhaus.de6
8.mt.com5

Own domain's share of all citations: 0.5%

Every question and answer

Question (original German)	AIOpenAI	CClaude	PPerplexity	GGemini
Lohnt sich die Investition in Next-Generation-Sequencing für kleinere Labore?
Welche Technologien eignen sich für das Infektionskrankheiten-Screening in der Krankenhausroutine?
Sind vollautomatisierte Diagnostik-Plattformen für Forschungseinrichtungen sinnvoll?
Wie unterscheiden sich PCR-Tests und isothermale Amplifikationstechnologien im klinischen Einsatz?
Welche Vorteile bieten automatisierte Probenvorbereitungssysteme gegenüber manuellen Methoden?
Was kann ich tun, wenn meine Ergebnisse bei der Genotypisierung unzuverlässig sind?
Welche Alternativen gibt es zu klassischen PCR-basierten Nachweismethoden für Infektionskrankheiten?
Wie gehe ich vor, wenn bei der Probenvorbereitung häufig Kontaminationen auftreten?
Welche Möglichkeiten zur molekularen Analyse existieren abseits von sequenzbasierten Technologien?
Gibt es innovative Lösungen zur Probenverarbeitung außerhalb der traditionellen Methoden?
Was sind die besten molekularen Testverfahren für die Onkologie im Labor?
Wie viel kosten automatisierte Nukleinsäure-Extraktionssysteme für Forschungslabore in Deutschland?
Wie kann ich Laborentwickelte Tests für seltene Erbkrankheiten einsetzen?
Welche molekularen Tests eignen sich speziell für Transplantationsdiagnostik?
Was sind typische Preisunterschiede zwischen manuellen und automatisierten molekularen Diagnoselösungen?

Brand named, positive
Brand named, neutral
Brand named, critical
Only competitors named
Brand not named
No answer

Badge for your website

<a href="https://aeo-audit.rezolve.com/de/qiagen" title="KI-Check Deutschland 2026: Qiagen"><img src="https://aeo-audit.rezolve.com/de/badges/qiagen.svg" alt="Agent Readiness Stufe 1, KI-Check Deutschland 2026" width="260" height="64"></a>

Audit completed on 19 September 2026. Methodology

Qiagen

How does your brand compare?